Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

The IGF1R/N-Cadherin/NCAM Signalling Complex: Delineation and Contribution to Medulloblastoma Invasion and Metastasis

FY 2009-10

Summary
Medulloblastoma is the most common brain tumour afflicting children, with almost seventy percent of cases occurring in kids younger than sixteen years old. One of the most severe manifestations of this disease is the spreading of the tumour from its primary site in the cerebellum to the surface of the brain and spinal cord. Once metastasis occurs, medulloblastoma becomes highly resistant to currently available treatment, resulting in a high morbidity rate. Even in cases where the cancer is successfully eradicated, the therapy leaves the patient with life-long side effects, such as neurocognitive deficits. Currently, very little is known about the basic biology behind medulloblastoma metastasis. Our lab has developed a model for this process using immortalized human medulloblastoma tumour cells. We have identified Insulin-like Growth factor 1 Receptor (IGF1R), N-Cadherin and Neural Cell Adhesion Molecule (NCAM) as key molecules involved in medulloblastoma adhesion and migration. This project will examine the specific molecular pathway initiated by these molecules and asses its contribution to medulloblastoma invasion by blocking each step of the signalling cascade. If successful, these results will not only lead to a greater understanding of the biochemical mechanism leading to medulloblastoma metastasis but also identify novel targets for more effective and less toxic drugs or therapies.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
200281
Name
Aref Donya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
The IGF1R/N-Cadherin/NCAM Signalling Complex: Delineation and Contribution to Medulloblastoma Invasion and Metastasis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adhesion Molecules; Co-Immunoprecipitation; Insulin-Like Growth Factor 1; Integrins; Leptomeningeal Spread; Medulloblastoma; Metastasis; Receptor Tyrosine Kinase; Rna Interference; Signalling Pathways
Abstract
Medulloblastoma is the most common brain tumour afflicting children, with almost seventy percent of cases occurring in kids younger than sixteen years old. One of the most severe manifestations of this disease is the spreading of the tumour from its primary site in the cerebellum to the surface of the brain and spinal cord. Once metastasis occurs, medulloblastoma becomes highly resistant to currently available treatment, resulting in a high morbidity rate. Even in cases where the cancer is successfully eradicated, the therapy leaves the patient with life-long side effects, such as neurocognitive deficits. Currently, very little is known about the basic biology behind medulloblastoma metastasis. Our lab has developed a model for this process using immortalized human medulloblastoma tumour cells. We have identified Insulin-like Growth factor 1 Receptor (IGF1R), N-Cadherin and Neural Cell Adhesion Molecule (NCAM) as key molecules involved in medulloblastoma adhesion and migration. This project will examine the specific molecular pathway initiated by these molecules and asses its contribution to medulloblastoma invasion by blocking each step of the signalling cascade. If successful, these results will not only lead to a greater understanding of the biochemical mechanism leading to medulloblastoma metastasis but also identify novel targets for more effective and less toxic drugs or therapies.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Aref, Donya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~